Evidence map›Paper›PMID 41837579›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Self-Adaptive Allantoin@ZIF8 Nanocomposite Hydrogel with Resveratrol Synergy for MRSA-Infected Wound Regeneration.

Yongjie Zhu, Dun Liu, Mengran Zhao, Xinyi Jian, Enuo Peng, Xingping Zhao, Zezhang Zhu, Bolin Tang, Benlong Shi

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yongjie ZhuDivision of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Dun LiuDivision of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Mengran ZhaoSchool of Materials and Textile Engineering, Jiaxing University, Jiaxing, China.
Xinyi JianSchool of Materials and Textile Engineering, Jiaxing University, Jiaxing, China.
Enuo PengDepartment of Gynecology, Third Xiangya Hospital, Central South University, Changsha, China.
Xingping ZhaoDepartment of Gynecology, Third Xiangya Hospital, Central South University, Changsha, China.
Zezhang ZhuDivision of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Bolin TangSchool of Materials and Textile Engineering, Jiaxing University, Jiaxing, China.
Benlong ShiDivision of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.ORCID https://orcid.org/0000-0002-0244-8525

Funding

China Postdoctoral Science Foundation 2024M761411Jiangsu Funding Program for Excellent Postdoctoral Talent 2025ZB047Jiaxing Public Welfare Research Project 2024AD10056National Natural Science Foundation of China 82302685National Natural Science Foundation of China 82502885National Natural Science Foundation Youth Cultivation Project of Nanjing Drum Tower Hospital 2024-JCYJ-QP-13Postdoctoral Fellowship Program and China Postdoctoral Science Foundation BX20250264The Science and Technology Program Project of Zhejiang Province 2025ZY01057
6 · The paper itself

Abstract

Infected wounds present a formidable challenge to healing due to their complex pathological microenvironment, whereas conventional dressings are often functionally limited and ill-suited to adapt to dynamic wound changes. In this study, based on allantoin-loaded ZIF8 nanoparticles (Alla@ZIF8) and methacrylated quaternary ammonium carboxymethyl chitosan/resveratrol composite hydrogels (RMQCC), we designed and developed an adaptive multifunctional hydrogel system (Alla@ZIF8-Gel). This nanocomposite hydrogel exhibited multiple intelligent features, including pH-responsiveness and morphological adaptability. The quaternary ammonium carboxymethyl chitosan imparted well biocompatibility and robust antimicrobial properties. Electrostatic interactions and hydrogen bonds endowed hydrogels with excellent injectability and self-healing capabilities. The ZIF8 nanoparticles enabled the intelligent, on-demand release of allantoin, thereby promoting tissue regeneration. Resveratrol conferred potent antioxidant, anti-inflammatory, and immunomodulatory effects. The Alla@ZIF8-Gel dynamically modulated drug release kinetics in response to the wound microenvironment, synergistically delivering antibacterial, antioxidant, anti-inflammatory, and tissue-regenerative functions. Both in vitro and in vivo experimental results demonstrated that this adaptive hydrogel markedly accelerated the healing of MRSA-infected wounds, suppressed bacterial proliferation, alleviated oxidative damage and inflammatory responses, and enhanced collagen deposition, re-epithelialization, and neovascularization. This work provides a novel design paradigm for the development of intelligent, multifunctional therapeutic materials for infected wound management, with significant translational potential for clinical application.

Indexed as

AllantoinHydrogelsImidazolesMethicillin-Resistant Staphylococcus aureusNanocompositesResveratrolStaphylococcal InfectionsWound HealingWound InfectionAnimalsAnti-Bacterial AgentsAntioxidantsMetal-Organic FrameworksMiceRegenerationAllantoinAnti-Bacterial AgentsAntioxidantsHydrogelsImidazolesMetal-Organic FrameworksResveratrolZIF-8 metal-organic frameworkallantoinantibacterial activityresveratrolwound healingzeolitic imidazolate framework 8

Identifiers

PMID41837579
PMCPMC13073323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.